DK3110970T3 - Biomarkører for endometriose - Google Patents

Biomarkører for endometriose Download PDF

Info

Publication number
DK3110970T3
DK3110970T3 DK15708041.7T DK15708041T DK3110970T3 DK 3110970 T3 DK3110970 T3 DK 3110970T3 DK 15708041 T DK15708041 T DK 15708041T DK 3110970 T3 DK3110970 T3 DK 3110970T3
Authority
DK
Denmark
Prior art keywords
endometriosis
biomarkers
Prior art date
Application number
DK15708041.7T
Other languages
English (en)
Inventor
Finbar Cotter
Christine Deguara
Colin Davis
Original Assignee
Univ London Queen Mary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London Queen Mary filed Critical Univ London Queen Mary
Application granted granted Critical
Publication of DK3110970T3 publication Critical patent/DK3110970T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/364Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
DK15708041.7T 2014-02-27 2015-02-27 Biomarkører for endometriose DK3110970T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201403489A GB201403489D0 (en) 2014-02-27 2014-02-27 Biomarkers for endometriosis
PCT/GB2015/050584 WO2015128671A1 (en) 2014-02-27 2015-02-27 Biomarkers for endometriosis

Publications (1)

Publication Number Publication Date
DK3110970T3 true DK3110970T3 (da) 2021-03-08

Family

ID=50490505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15708041.7T DK3110970T3 (da) 2014-02-27 2015-02-27 Biomarkører for endometriose

Country Status (8)

Country Link
US (4) US20170016067A1 (da)
EP (1) EP3110970B1 (da)
JP (1) JP6667446B2 (da)
AU (2) AU2015221951A1 (da)
BR (1) BR112016019836A2 (da)
DK (1) DK3110970T3 (da)
GB (1) GB201403489D0 (da)
WO (1) WO2015128671A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3800267A1 (en) 2014-03-27 2021-04-07 Yale University Circulating micrornas as biomarkers for endometriosis
WO2017119510A1 (ja) * 2016-01-08 2017-07-13 国立大学法人京都大学 乳がんの診断のための検査方法、遺伝子マーカー、および検査薬
MX2019002425A (es) 2016-08-30 2019-08-16 Univ Yale Micro ácidos ribonucleicos como biomarcadores para la endometriosis.
CN107858416B (zh) * 2016-09-19 2021-05-28 深圳华大生命科学研究院 用于子宫内膜异位症检测的生物标志物组合及其应用
TWI682034B (zh) 2017-03-10 2020-01-11 長庚醫療財團法人林口長庚紀念醫院 用於評估子宮內膜癌的發展風險或診斷子宮內膜癌的方法
CN106967813A (zh) * 2017-04-18 2017-07-21 上海润达榕嘉生物科技有限公司 一种用于子宫内膜异位症诊断的试剂盒及其检测方法
WO2019046494A1 (en) * 2017-08-30 2019-03-07 Dot Laboratories, Inc. METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF ENDOMETRIOSIS
US12286629B2 (en) 2018-07-13 2025-04-29 Yale University Compositions and methods for treating endometriosis
WO2020092672A2 (en) * 2018-10-31 2020-05-07 Yale University A quantitative algorithm for endometriosis
US11315660B2 (en) * 2018-10-31 2022-04-26 Dot Laboratories, Inc. Method of detecting and treating endometriosis in a female subject
WO2020218465A1 (ja) * 2019-04-26 2020-10-29 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット
BR112021021866A2 (pt) * 2019-04-29 2021-12-21 Dot Laboraties Inc Classificadores para a detecção de endometriose
EP4004555A1 (en) * 2019-07-22 2022-06-01 F. Hoffmann-La Roche AG S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013783A1 (en) * 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021024331A1 (ja) 2019-08-02 2021-02-11 株式会社 東芝 分析方法及びキット
US11965879B2 (en) 2019-08-23 2024-04-23 Mcmaster University Method for diagnosing and assessing endometriosis
CN110804659B (zh) * 2019-10-23 2023-02-03 华南农业大学 一种血清外泌体ssc-miR-92b-3p作为母猪早期妊娠诊断分子标志物的应用
EP4051127A4 (en) * 2019-11-01 2024-02-28 NextGen Jane, Inc. METHODS AND SYSTEMS FOR MENSTRUAL ANALYSIS
BR102021022687A2 (pt) * 2020-12-11 2022-06-28 Euroimmun Medizinische Labordiagnostika Ag Método e reagentes para diagnosticar nefropatia membranosa
CN115725494B (zh) * 2022-11-09 2024-11-15 华南农业大学 ssc-miR-92b-3p在促进猪胚胎附植中的应用
KR102940037B1 (ko) * 2022-12-06 2026-03-16 연세대학교 산학협력단 자궁내막증 진단용 조성물
FR3143174A1 (fr) * 2022-12-12 2024-06-14 Ziwig Procede d’identification de biomarqueurs d’arn extracellulaires dans des echantillons de fluide corporel en vue de detecter des cancers et d’autres pathologies telles que l’endometriose
CN118531129A (zh) * 2024-05-06 2024-08-23 浙江大学 一种与绵羊妊娠阶段差异表达相关的分子标记及其应用
CN120118996B (zh) * 2025-03-06 2025-09-05 三二〇一医院 血浆miR-9和miR-106a作为胃癌患者腹膜癌变的诊断标志物及其相关产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0421639D0 (en) * 2004-09-29 2004-10-27 Proteome Sciences Plc Methods and compositions relating to alzheimer's disease
WO2006098144A1 (ja) * 2005-03-17 2006-09-21 National University Corporation Chiba University 特発性肺線維症の検出マーカー、検出キット及び検出方法
JP5495159B2 (ja) * 2006-09-13 2014-05-21 オンクイミューン リミテッド 改善されたイムノアッセイ法
WO2010021843A1 (en) * 2008-08-20 2010-02-25 Eli Lilly And Company Use of antifolates in patients with detectable levels of tff-1 for the cancer treatment
JPWO2010101047A1 (ja) * 2009-03-06 2012-09-06 持田製薬株式会社 子宮内膜症の判定方法、および子宮内膜症の診断用キット
GB201012662D0 (en) * 2010-07-28 2010-09-15 Valirx Plc Method for detecting the presence of a gynaecological growth
WO2012119051A2 (en) * 2011-03-02 2012-09-07 Groove Biopharma Corporation Enhanced biodistribution of oligomers
WO2012142330A1 (en) * 2011-04-15 2012-10-18 Brown University Micro rnas as diagnostic biomarkers and therapeutics for ovarian cancer and metastatic tumors that disseminate within the peritoneal cavity
JP2015504307A (ja) * 2011-11-22 2015-02-12 インターミューン, インコーポレイテッド 特発性肺線維症を診断および治療する方法
US20150057173A1 (en) * 2012-03-19 2015-02-26 Prestizia Methods for determining the tropism and receptor usage of a virus, in particular hiv, in body samples taken from the circulation
EP2857521A4 (en) * 2012-05-31 2015-12-30 Takeda Pharmaceutical METHOD FOR ASSESSING ENDOMETRIOSIS

Also Published As

Publication number Publication date
JP2017509333A (ja) 2017-04-06
US20230108685A1 (en) 2023-04-06
US20190233892A1 (en) 2019-08-01
EP3110970A1 (en) 2017-01-04
US20170016067A1 (en) 2017-01-19
EP3110970B1 (en) 2020-12-02
AU2015221951A1 (en) 2016-09-15
JP6667446B2 (ja) 2020-03-18
BR112016019836A2 (pt) 2017-10-17
GB201403489D0 (en) 2014-04-16
AU2021203378A1 (en) 2021-06-24
WO2015128671A1 (en) 2015-09-03
US20210147938A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
NL301352I2 (nl) epcoritamab
NL301246I1 (nl) Glofitamab
NL301172I1 (nl) Lonapegsomatropine
DK3110970T3 (da) Biomarkører for endometriose
IL251963A0 (en) Anti-pd-1 antibodies
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
FIC20265009I1 (fi) Brensocatib
DK3006072T3 (da) Karadgang
DK3222714T3 (da) Phytasemutanter
DK3119396T3 (da) Muscarinreceptoragonister
EP3230438C0 (en) N-GLYCOSYLATION
DK3125898T3 (da) Farmakofor til trail-induktion
EP4011484C0 (en) CARBONIC ANHYDRASE OF THERMOVIBRIO AMMONIFICANS
DK4242916T3 (da) Forstøver
DK3183340T3 (da) Termolabile exonukleaser
DE112015001664A5 (de) Betätigungsaktuator
DK3154703T3 (da) Fuldkappe-snekkecentrifuge
DE112015005041A5 (de) Gargerätevorrichtung
DK3110439T3 (da) Pcsk9-vacciner
DE102014000623A8 (de) Halbhohlnietelement
HUE054148T2 (hu) Anti-ORAI1 antitest
LT3126391T (lt) Hpa-1a antikūnai
DK3009858T3 (da) Skyradar